Genetic determinants of apolipoprotein B-100 kinetics

Current Opinion in Lipidology

Volumn 21, Issue 2, 2010, Pages 141-147

  Ng, Theodore W K ^a   Ooi, Esther M M ^a   Watts, Gerald F ^a   Chan, Dick C ^a   Barrett, P Hugh R ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Apolipoprotein B 100; Gene polymorphisms; Kinetics; Stable isotopes

Indexed keywords

ABC TRANSPORTER; APOLIPOPROTEIN B100; CHOLESTEROL ESTER TRANSFER PROTEIN; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; NUCLEAR PROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PROTEIN CETP B1B1; PROTEIN NIEMANN PICK C1 LIKE 1; PROTEIN SP24; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; CARRIER PROTEIN; SIGNAL PEPTIDE; TRIACYLGLYCEROL LIPASE;

ARTICLE; ENZYME ACTIVITY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; LIPOPROTEIN METABOLISM; MICROSOME; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN SECRETION; ANIMAL; CHEMISTRY; GENETICS; KINETICS; METABOLISM; MUTATION; REVIEW; SECRETION;

ANIMALS; APOLIPOPROTEIN B-100; CARRIER PROTEINS; HUMANS; KINETICS; LIPASE; MUTATION; PROTEIN SORTING SIGNALS;

EID: 77957331389     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3283378e5a     Document Type: Article

References (55)

1. Burnett JR, Barrett PH. Apolipoprotein B metabolism: tracer kinetics, models, and metabolic studies. Crit Rev Clin Lab Sci 2002; 39:89-137. (Pubitemid 34492990)
2. Barrett PHR, Foster DM. Design and analysis of lipid tracer kinetic studies. Curr Opin Lipidol 1996; 7:143-148. (Pubitemid 26234226)
3. Parhofer KG, Barrett PH. Thematic review series: patient-oriented research. What we have learned about VLDL and LDL metabolism from human kinetics studies. J Lipid Res 2006; 47:1620-1630. (Pubitemid 44222814)
4. Benhizia F, Reina M, Sturley S, et al. Variations in the human apolipoprotein B signal peptide alter apoB secretion and degradation in McArdle RH-7777 rat hepatoma cells. Atherosclerosis 1997; 134:65. (abstract).
5. Karpe F, Lundahl B, Ehrenborg E, et al. A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. Arterioscler Thromb Vasc Biol 1998; 18: 756-761. (Pubitemid 28267655)
6. Wu X, Zhou M, Huang LS, et al. Demonstration of a physical interaction between microsomal triglyceride transfer protein and apolipoprotein B during the assembly of ApoB-containing lipoproteins. J Biol Chem 1996; 271:10277-10281. (Pubitemid 26132519)
7. Myant NB, Gallagher J, Barbir M, et al. Restriction fragment length polymorphisms in the apo B gene in relation to coronary artery disease. Atherosclerosis 1989; 77:193-201. (Pubitemid 19136720)
8. Renges HH, Wile DB, McKeigue PM, et al. Apolipoprotein B gene polymorphisms are associated with lipid levels in men of South Asian descent. Atherosclerosis 1991; 91:267-275.
9. Riches FM, Watts GF, van Bockxmeer FM, et al. Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men. J Lipid Res 1998; 39:1752-1758. (Pubitemid 28411162)
10. Hussain MM, Shi J, Dreizen P. Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly. J Lipid Res 2003; 44:22-32. (Pubitemid 36114766)
11. Ledmyr H, Karpe F, Lundahl B, et al. Variants of the microsomal triglyceride transfer protein gene are associated with plasma cholesterol levels and body mass index. J Lipid Res 2002; 43:51-58. (Pubitemid 34117217)
12. Ledmyr H, McMahon AD, Ehrenborg E, et al. The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease. Circulation 2004; 109:2279-2284. (Pubitemid 38656866)
13. Couture P, Otvos JD, Cupples LA, et al. Absence of association between genetic variation in the promoter of the microsomal triglyceride transfer protein gene and plasma lipoproteins in the Framingham Offspring Study. Atherosclerosis 2000; 148:337-343. (Pubitemid 30064465)
14. Juo SH, Han Z, Smith JD, et al. Common polymorphism in promoter of microsomal triglyceride transfer protein gene influences cholesterol, ApoB, and triglyceride levels in young African American men: results from the coronary artery risk development in young adults (CARDIA) study. Arterioscler Thromb Vasc Biol 2000; 20:1316-1322. (Pubitemid 30262933)
15. Watts GF, Riches FM, Humphries SE, et al. Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity. J Lipid Res 2000; 41:481-488. (Pubitemid 30183631)
16. Fumeron F, Betoulle D, Luc G, et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 1995; 96:1664-1671.
17. Lundahl B, Skoglund-Andersson C, Caslake M, et al. Microsomal triglyceride transfer protein-493T variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles. Am J Physiol Endocrinol Metab 2006; 290:E739-E745.
18. Chan DC, Watts GF, Barrett PHR, et al. ATP-binding cassette transporter G8 gene as a determinant of apolipoprotein B-100 kinetics in overweight men. Arterioscler Thromb Vasc Biol 2004; 24:2188-2191. (Pubitemid 39482450)
19. Hubacek JA, Berge KE, Cohen JC, Hobbs HH. Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia. Hum Mutat 2001; 18:359-360.
20. Davies JP, Scott C, Oishi K, et al. Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia. J Biol Chem 2005; 280:12710-12720.
21. Davies JP, Ioannou YA. The role of the Niemann-Pick C1-like 1 protein in the subcellular transport of multiple lipids and their homeostasis. Curr Opin Lipidol 2006; 17:221-226. (Pubitemid 43786054)
22. Chan DC, Watts GF, Wang J, et al. Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese men. Clin Endocrinol 2008; 69:45-51. (Pubitemid 351847259)
23. Yu L, Li-Hawkins J, Hammer RE, et al. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 2002; 110:671-680. (Pubitemid 34988791)
24. Temel RE, Tang W, Ma Y, et al. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest 2007; 117:1968-1978. (Pubitemid 47036331)
25. Otarod JK, Goldberg IJ. Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk. Curr Atheroscler Rep 2004; 6:335-342. (Pubitemid 39359474)
26. Merkel M, Eckel RH, Goldberg IJ. Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res 2002; 43:1997-2006. (Pubitemid 35471065)
27. Beisiegel U, Weber W, Bengtsson-Olivecrona G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci U S A 1991; 88:8342-8346. (Pubitemid 21915352)
28. Murthy V, Julien P, Gagne C. Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol Ther 1996; 70:101-135. (Pubitemid 26233576)
29. Sagoo GS, Tatt I, Salanti G, et al. Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am J Epidemiol 2008; 168:1233-1246.
30. Perez-Mendez O, Duhal N, Lacroix B, et al. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene. Clin Chim Acta 2006; 368:149-154. (Pubitemid 43776031)
31. Nierman MC, Prinsen BH, Rip J, et al. Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers. Arterioscler Thromb Vasc Biol 2005; 25:2410-2415. (Pubitemid 41552663)
32. Nierman MC, Rip J, Kuivenhoven JA, et al. Carriers of the frequent lipoprotein lipase S447X variant exhibit enhanced postprandial apoprotein B-48 clearance. Metabolism 2005; 54:1499-1503. (Pubitemid 41527020)
33. Ross CJ, Liu G, Kuivenhoven JA, et al. Complete rescue of lipoprotein lipase-deficient mice by somatic gene transfer of the naturally occurring LPLS447X beneficial mutation. Arterioscler Thromb Vasc Biol 2005; 25:2143-2150. (Pubitemid 41416313)
34. Santamarina-Fojo S, Gonzalez-Navarro H, Freeman L, et al. Hepatic lipase, lipoprotein metabolism, and atherogenesis. Arterioscler Thromb Vasc Biol 2004; 24:1750-1754. (Pubitemid 39350288)
35. Jansen H, van Tol A, Hulsmann WC. On the metabolic function of heparin-releasable liver lipase. Biochem Biophys Res Commun 1980; 92:53-59. (Pubitemid 10137379)
36. Jansen H, Verhoeven AJ, Sijbrands EJ. Hepatic lipase: a pro-or antiathero-genic protein? J Lipid Res 2002; 43:1352-1362.
37. Syvanne M, Ahola M, Lahdenpera S, et al. High density lipoprotein subfractions in noninsulin-dependent diabetes mellitus and coronary artery disease. J Lipid Res 1995; 36:573-582.
38. Groot PH, van Stiphout WA, Krauss XH, et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991; 11:653-662.
39. Hegele RA, Little JA, Vezina C, et al. Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb 1993; 13:720-728. (Pubitemid 23141762)
40. Knudsen P, Antikainen M, Uusi-Oukari M, et al. Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL gene. Atherosclerosis 1997; 128:165-174. (Pubitemid 27092151)
41. Ruel IL, Couture P, Gagne C, et al. Characterization of a novel mutation causing hepatic lipase deficiency among French Canadians. J Lipid Res 2003; 44:1508-1514. (Pubitemid 37279595)
42. Demant T, Carlson LA, Holmquist L, et al. Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J Lipid Res 1988; 29:1603-1611. (Pubitemid 19030528)
43. Tilly-Kiesi M, Schaefer EJ, Knudsen P, et al. Lipoprotein metabolism in subjects with hepatic lipase deficiency. Metabolism 2004; 53:520-525. (Pubitemid 38419198)
44. McLean J, Wion K, Drayna D, et al. Human lecithin-cholesterol acyltransferase gene: complete gene sequence and sites of expression. Nucleic Acids Res 1986; 14:9397-9406.
45. Santamarina-Fojo S, Lambert G, Hoeg JM, Brewer HB Jr. Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis. Curr Opin Lipidol 2000; 11:267-275. (Pubitemid 30336024)
46. Rader DJ, Ikewaki K, Duverger N, et al. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease. J Clin Invest 1994; 93:321-330.
47. Nishiwaki M, Ikewaki K, Bader G, et al. Human lecithin: cholesterol acyltrans-ferase deficiency: in vivo kinetics of low-density lipoprotein and lipoprotein-X. Arterioscler Thromb Vasc Biol 2006; 26:1370-1375. (Pubitemid 44305384)
48. Twisk J, Gillian-Daniel DL, Tebon A, et al. The role of the LDL receptor in apolipoprotein B secretion. J Clin Invest 2000; 105:521-532.
49. Hesler CB, Swenson TL, Tall AR. Purification and characterization of a human plasma cholesteryl ester transfer protein. J Biol Chem 1987; 262:2275-2282. (Pubitemid 17102658)
50. Barter PJ. Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors. Atheroscler Suppl 2002; 3:39-47. (Pubitemid 38234485)
51. Ikewaki K, Rader DJ, Sakamoto T, et al. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. J Clin Invest 1993; 92:1650-1658. (Pubitemid 23304526)
52. Inazu A, Brown ML, Hesler CB, et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 1990; 323:1234-1238. (Pubitemid 20366528)
53. Ikewaki K, Nishiwaki M, Sakamoto T, et al. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency. J Clin Invest 1995; 96:1573-1581.
54. Barrett PH, Chan DC, Watts GF. Thematic review series: patient-oriented research. Design and analysis of lipoprotein tracer kinetics studies in humans. J Lipid Res 2006; 47:1607-1619. (Pubitemid 44222813)
55. Chan DC, Barrett PH, Watts GF. Lipoprotein transport in the metabolic syndrome: methodological aspects of stable isotope kinetic studies. Clin Sci (Lond) 2004; 107:221-232. (Pubitemid 39243881)